Presentation TCT 2016 TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy October 31, 2016
Presentation TCT 2016 Real-world Watchman Outcomes: Insights From the EWOLUTION European Registry Presenter: Vivek Y. Reddy, Steven J. Yakubov, Martin W. Bergmann October 30, 2016
Presentation TCT 2016 Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven? Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr. October 30, 2016
Presentation TCT 2016 Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness) Presenter: Vivek Y. Reddy, Steven J. Yakubov October 30, 2016
News Opinion Editor's Corner TCT 2016 TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever Shelley Wood October 24, 2016
News Daily News Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests Todd Neale July 28, 2016
News Daily News Según una Revisión las Evidencias que Avalan la Exclusión Percutánea o Quirúrgica del AAI para la Prevención de ACV son Limitadas Todd Neale July 14, 2016
News Daily News Evidence Supporting Percutaneous or Surgical LAA Exclusion for Stroke Prevention Is Limited, Review Says Todd Neale July 14, 2016